[D-Ala2]-Deltorphin II peptide
Not For Human Use, Lab Use Only.
Cat.#: 300420
Special Price 109.40 USD
-
Product Name
[D-Ala2]-Deltorphin II peptide
-
Documents
Batch to batch variation of the purity
-
Sequence Shortening
YaFEVVG-NH2
-
Sequence
Y-{d-Ala}-FEVVG-NH2
-
Length (aa)
7
-
Peptide Purity (HPLC)
95.7%
-
Molecular Formula
C38H54N8O10
-
Molecular Weight
782.9
-
CAS No.
122752-16-3
-
Source
Synthetic
-
Form
Powder
-
Description
[D-Ala2]deltorphin II is a highly stable amphibian heptapeptide and one of the most potent and selective δ-opioid receptor agonists known, with higher affinity and selectivity for δ-opioid receptors than any endogenous mammalian opioid ligand. It exhibits favorable enzymatic stability in brain membrane homogenates and plasma, with its blood-brain barrier (BBB) permeability influenced by its N-terminal region and residues at positions 4 and 5.
In mice, intracerebroventricular administration of [D-Ala2]deltorphin II produces significant antinociceptive effects, and repeated exposure leads to marked homologous tolerance without cross-tolerance to the δ₁ agonist DPDPE or the μ agonist DAMGO, indicating distinct receptor regulatory mechanisms.
It acts as a selective δ₂-opioid receptor agonist, whose antinociceptive signaling is coupled to Gq proteins and involves inositol-signaling pathways, distinguishing it from δ₁ agonists such as DPDPE, which rely on Go1 proteins.
-
Storage Guidelines
Normally, this peptide will be delivered in lyophilized form and should be stored in a freezer at or below -20 °C. For more details, please refer to the manual: Handling and Storage of Synthetic Peptides
-
References
- Thomas SA, Abbruscato TJ, Hau VS, et al. Structure-activity relationships of a series of [D-Ala2]deltorphin I and II analogues; in vitro blood-brain barrier permeability and stability. J Pharmacol Exp Ther. 1997;281(2):817-825.
- Mattia A, Vanderah T, Mosberg HI, Porreca F. Lack of antinociceptive cross-tolerance between [D-Pen2, D-Pen5]enkephalin and [D-Ala2]deltorphin II in mice: evidence for delta receptor subtypes. J Pharmacol Exp Ther. 1991 Aug;258(2):583-7. PMID: 1650835.
- Sánchez-Blázquez P, Garzón J. delta Opioid receptor subtypes activate inositol-signaling pathways in the production of antinociception. J Pharmacol Exp Ther. 1998 May;285(2):820-7. PMID: 9580632.
-
About TFA salt
Trifluoroacetic acid (TFA) is a common counterion from the purification process using High-Performance Liquid Chromatography (HPLC). The presence of TFA can affect the peptide's net weight, appearance, and solubility.
Impact on Net Weight: The TFA salt contributes to the total mass of the product. In most cases, the peptide content constitutes >80% of the total weight, with TFA accounting for the remainder.
Solubility: TFA salts generally enhance the solubility of peptides in aqueous solutions.
In Biological Assays: For most standard in vitro assays, the residual TFA levels do not cause interference. However, for highly sensitive cellular or biochemical studies, please be aware of its presence.
-
Molar Concentration Calculator
-
Dilution Calculator
-
Percent Concentration Calculator
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
Related Products / Services
• Peptide Services: NovoPro's peptide synthesis services include standard chemical peptide synthesis, peptide modification, peptide libraries, and recombinant peptide expression.
• Standard Peptide Synthesis: NovoPro offers quality peptides at the most competitive prices in the industry, starting at $3.20 per amino acid. NovoPro provides PepBox – Automatic Quote Tool for online price calculation.
• Peptide Modifications: NovoPro offers a wide range of peptide modification services including isotope labeling (2H, 15N, and 13C), multiple disulfide bonds, multiple phosphorylations, KLH, BSA, ovalbumin, amidation, acetylation, biotin, FITC, etc.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"